APA (7th ed.) Citation

SMITH, P. K., GOODNOUGH, L. T., LEVY, J. H., POSTON, R. S., SHORT, M. A., WEERAKKODY, G. J., & LENARZ, L. A. (2012). Mortality Benefit With Prasugrel in the TRITON―TIMI 38 Coronary Artery Bypass Grafting Cohort: Risk-Adjusted Retrospective Data Analysis. Journal of the American College of Cardiology, 60(5), 388-396. https://doi.org/10.1016/j.jacc.2012.03.030

Chicago Style (17th ed.) Citation

SMITH, Peter K., Lawrence T. GOODNOUGH, Jerrold H. LEVY, Robert S. POSTON, Mary A. SHORT, Govinda J. WEERAKKODY, and Leroy A. LENARZ. "Mortality Benefit With Prasugrel in the TRITON―TIMI 38 Coronary Artery Bypass Grafting Cohort: Risk-Adjusted Retrospective Data Analysis." Journal of the American College of Cardiology 60, no. 5 (2012): 388-396. https://doi.org/10.1016/j.jacc.2012.03.030.

MLA (9th ed.) Citation

SMITH, Peter K., et al. "Mortality Benefit With Prasugrel in the TRITON―TIMI 38 Coronary Artery Bypass Grafting Cohort: Risk-Adjusted Retrospective Data Analysis." Journal of the American College of Cardiology, vol. 60, no. 5, 2012, pp. 388-396, https://doi.org/10.1016/j.jacc.2012.03.030.